AZD7594 + Placebo to match
Phase 1Completed 1 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Safety
Conditions
Safety, Pharmacokinetics, Pharmacodynamics of AZD7594
Trial Timeline
Sep 1, 2012 → Jun 1, 2013
NCT ID
NCT01636024About AZD7594 + Placebo to match
AZD7594 + Placebo to match is a phase 1 stage product being developed by AstraZeneca for Safety. The current trial status is completed. This product is registered under clinical trial identifier NCT01636024. Target conditions include Safety, Pharmacokinetics, Pharmacodynamics of AZD7594.
What happened to similar drugs?
3 of 4 similar drugs in Safety were approved
Approved (3) Terminated (0) Active (1)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01636024 | Phase 1 | Completed |
Competing Products
20 competing products in Safety